A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report

Capecitabine is an oral fluoropyrimidine which can prolong QT interval. However, there have been no reports that capecitabine induced ventricular fibrillation (VF) due to secondary QT prolongation in patients with no structural heart disease. A 39-year-old woman developed VF during the chemotherapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cardiol Cases
Main Authors: Hayasaka, Kazuto, Takigawa, Masateru, Takahashi, Atsushi, Kuwahara, Taishi, Okubo, Kenji, Tanaka, Yasuaki, Misawa, Toru, Mizusawa, Masafumi, Yamakami, Yosuke, Kojima, Keisuke, Sagawa, Yuichiro, Hishikari, Keiichi, Yamao, Kazuya, Nakashima, Emiko, Nakajima, Jun, Kimura, Shigeki, Takagi, Katsumasa, Hikita, Hiroyuki, Isobe, Mitsuaki
Formato: Artigo
Idioma:Inglês
Publicado em: Japanese College of Cardiology 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149258/
https://ncbi.nlm.nih.gov/pubmed/30279790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2017.03.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados